Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors

Thumbnail Image
739b2e31-abfb-4a1b-aa65-5f42af0c2dee_assessing_the_risk_of_cardiovascular_events_in_patients_receiving_immune_checkpoint_inhibitors_UPW.pdf (674.29 KB)
Identifiers
URI: https://hdl.handle.net/10641/6590
ISSN: 2297-055X
DOI: 10.3389/fcvm.2022.1062858

Publication date

2022-12-01

Start date of the public exhibition period

End date of the public exhibition period

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Share
Export

Research Projects

Organizational Units

Journal Issue

Doctoral program

Description

Keywords

Cardiotoxicity, Cardiovascular event, Immune checkpoint inhibitors, Myocarditis, Risk factors, SDG 3 - Good Health and Well-being, Journal Article, Yes, yes

Citation

Torrente, M, Blanco, M, Franco, F, Garitaonaindia, Y, Calvo, V, Collazo-Lorduy, A, Gutierrez, L, Cristobal Sanchez, J, Gonzalez-del-Alba, A, Hernandez, R, Mendez, M, Cantos, B, Nunez, B, Sousa, P A C & Provencio, M 2022, 'Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors', Frontiers in Cardiovascular Medicine, vol. 9, 1062858. https://doi.org/10.3389/fcvm.2022.1062858

Collections

FACULTAD DE CIENCIAS DE LA SALUD